Condition
Neoadjuvant Therapies clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Neoadjuvant Therapies clinical trials that are recruiting, in China. By phase: Phase 2 (4), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Neoadjuvant Therapies clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Node-sparing low-dose radiotherapy combined with chemotherapy and PD-1 blocker for high-risk pMMR/MSS locally advanced colon cancer. | Phase 2 | Guangzhou, Guangdong | Recruiting | Dec 12, 2025 |
| Node-sparing hypofractionated radiotherapy with chemotherapy and PD-1 blockade for high-risk MSS/pMMR locally advanced colon cancer | Phase 2 | Guangzhou, Guangdong | Recruiting | Nov 17, 2025 |
| Node-sparing radiotherapy with chemotherapy and PD-1 inhibitor for rectal cancer | Phase 2/3 | Guangzhou, Guangdong | Recruiting | May 6, 2025 |
| Combining long-course radiotherapy, chemotherapy, and PD-1 inhibitor for high-risk rectal cancer | Phase 2 | Guangzhou, Guangdong | Recruiting | Apr 11, 2025 |
| Using sorbitol with chemotherapy and immunotherapy for advanced gastric cancer | Phase 2 | Wuhan, Hubei | Recruiting | Feb 13, 2025 |
All recruiting trials (5)
-
Node-sparing low-dose radiotherapy combined with chemotherapy and PD-1 blocker for high-risk pMMR/MSS locally advanced colon cancer.
This trial tests whether adding node-sparing low-dose radiotherapy to standard chemotherapy and a PD-1 blocker can improve tumor response in adults with high-risk, locally advanced pMMR/MSS colon cancer before surgery.
-
Node-sparing hypofractionated radiotherapy with chemotherapy and PD-1 blockade for high-risk MSS/pMMR locally advanced colon cancer
This trial will test whether node-sparing, short-course radiotherapy combined with chemotherapy and a PD-1 blocker can improve pre-surgery tumor response in adults with high-risk, microsatellite-stable (pMMR/MSS) locally advanced colon cancer.
-
Node-sparing radiotherapy with chemotherapy and PD-1 inhibitor for rectal cancer
This study is testing a new treatment for mid-low rectal cancer that combines special radiation, chemotherapy, and an immune booster to see if it helps patients respond better while protecting their lymph nodes.
-
Combining long-course radiotherapy, chemotherapy, and PD-1 inhibitor for high-risk rectal cancer
This study is testing a new treatment plan that combines radiation, chemotherapy, and a PD-1 inhibitor to see if it helps people with high-risk rectal cancer do better than with standard treatments.
-
Using sorbitol with chemotherapy and immunotherapy for advanced gastric cancer
This study is testing if adding sorbitol to standard chemotherapy and immunotherapy can help people with advanced gastric cancer feel better and improve their treatment results.
Related topics
Quick answers
How many Neoadjuvant Therapies clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.